8,758 reports of this reaction
3.1% of all NAPROXEN reports
#2 most reported adverse reaction
PAIN is the #2 most commonly reported adverse reaction for NAPROXEN, manufactured by ANI Pharmaceuticals, Inc.. There are 8,758 FDA adverse event reports linking NAPROXEN to PAIN. This represents approximately 3.1% of all 280,499 adverse event reports for this drug.
NAPROXEN has an overall safety score of 85 out of 100. Patients taking NAPROXEN who experience pain should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
PAIN is moderately reported among NAPROXEN users, representing a notable but not dominant share of adverse events.
In addition to pain, the following adverse reactions have been reported for NAPROXEN:
The following drugs have also been linked to pain in FDA adverse event reports:
PAIN has been reported as an adverse event in 8,758 FDA reports for NAPROXEN. This does not prove causation, but indicates an association observed in post-market surveillance data.
PAIN accounts for approximately 3.1% of all adverse event reports for NAPROXEN, making it one of the most commonly reported side effect.
If you experience pain while taking NAPROXEN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.